Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Jan 5, 2021
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-12-31$2.42/sh−30$73→ 16,694 total
Footnotes (1)
- [F1]The number of ordinary shares reported on this Form 4 reflects a 1-for-10 reverse stock split effected on December 3, 2020.